Variants of hepatitis A virus (pHM175 virus) recovered from persistently infected green monkey kidney (BS-C-1) cells induced a cytopathic effect during serial passage in BS-C-1 or fetal rhesus kidney (FRhK-4) cells. Epitope-specific radioimmunofocus assays showed that this virus comprised two virion populations, one with altered antigenicity including neutralization resistance to monoclonal antibody K24F2, and the other with normal antigenic characteristics. Replication of the antigenic variant was favored over that of virus with the normal antigenic phenotype during persistent infection, while virus with the normal antigenic phenotype was selected during serial passage. Viruses of each type were clonally isolated; both were cytopathic in cell cultures and displayed a rapid replication phenotype when compared with the noncytopathic passage 16 (p16) HM175 virus which was used to establish the original persistent infection. The two cytopathic virus clones contained 31 and 34 nucleotide changes from the sequence of p16 HM175. Both shared a common 5' sequence (bases 30 to 1677), as well as sequence identity in the P2-P3 region (bases 3249 to 5303 and 6462 to 6781) and 3' terminus (bases 7272 to 7478). VP3, VP1, and 3CPr0 contained different mutations in the two virus clones, with amino acid substitutions at residues 70 of VP3 and 197 and 276 of VP1 of the antigenic variant. These capsid mutations did not affect virion thermal stability. A comparison of the nearly complete genomic sequences of three clonally isolated cytopathic variants was suggestive of genetic recombination between these viruses during persistent infection and indicated that mutations in both 5' and 3' nontranslated regions and in the nonstructural proteins 2A, 2B, 2C, 3A, and 3DPo' may be related to the cytopathic phenotype.
Hepatitis A virus (HAV) is unique among human picornaviruses with respect to its tropism for liver cells and its capacity to induce acute hepatocellular injury (25) . A variety of primate cell types have been shown to be permissive for HAV, but most wild-type virus isolates replicate very slowly in cell culture (4, 11, 17, 35) . Although more rapid replication and higher final yields are achieved with virus that has been adapted to growth in cell culture, even highly cell cultureadapted HAV variants replicate considerably more slowly and less efficiently than poliovirus. In almost all cases, wild-type or low-passage virus does not induce visible cytopathic effects, and there is no evidence that HAV interferes with host cell macromolecular synthesis (19) . In vitro infections generally result in the establishment of persistent infection (41) , a curious finding since viral persistence is not known to occur in vivo (25) .
Several HAV variants have been reported to induce a cytopathic effect in monkey kidney cell and diploid human lung fibroblast cultures (1, 10, 21, 32, 42) . In at least three instances, these cytopathic variants have emerged during continued passage of persistently infected cell cultures (1, 10, 32) . An important attribute of these cytopathic variants, each derived from the HM175 strain of HAV, is that they appear to be uniquely well adapted to growth in cell culture. One such variant (10) replicates significantly more rapidly than its noncytopathic precursor, with maximum virus yields passages: 6 passages in BS-C-1 cells following 10 passages in AGMK cells (22) . Persistent infection of BS-C-1 cells was established with uncloned p16 HM175 virus as described previously (9, 10) . The cytopathic pHM175 virus (10) was recovered by disruption of these persistently infected cells after 21 to 23 subculture passages made at 2-to 4-week intervals. Unless otherwise noted, pHM175 virus stock had been serially passaged four times at low multiplicity of infection in FRhK-4 cells. By serial passage, we mean the passage in uninfected cells of virus recovered by disruption of infected cells. Two cytopathic clonal variants were selected from pHM175 harvests as described in Results. Clone A (HM175/43c virus) was twice plaque purified from neutral red-stained overlays of FRhK-4 cells inoculated with pHM175 virus and was selected for its ability to induce clearly visible plaques in this cell line. Clone A stock virus was propagated in FRhK-4 cells. Clone B (HM175/18f virus) was twice clonally isolated from agarose overlying foci of viral replication in radioimmunofocus assays by using previously described techniques (29) ; it was selected for continued reactivity with monoclonal antibody K24F2 (see Results). Clone B stock virus was propagated in BS-C-1 cells. In addition, a third clonal isolate, clone C (HM175/24a) was isolated from pHM175 virus stock by classical plaque purification techniques and propagated in FRhK-4 cells (9) .
For comparison of the growth properties of pHM175 antigenic variants during serial and persistent passage, 25-cm2 flasks containing nearly confluent cultures of FRhK-4 or BS-C-1 cells were inoculated with virus at an estimated multiplicity of infection of 0.01 to 0.1. Virus was harvested after 3 to 4 days (serial passage) or at 7-to 14-day intervals (persistent infection, when cells were subcultured) by freeze-thawing cells in 2 to 5 ml of Hanks balanced salt solution. Virus harvests were clarified by centrifugation in a microcentrifuge for 15 min and then extracted with an equal volume of chloroform before assay.
Plaque assay for cytopathic HAV. Conventional plaque assays were done with either FRhK-4 or BS-C-1 cells. Following inoculation with pHM175 virus, cell sheets were overlaid with 0.5% agarose (Seakem ME, Rockland, Maine) containing 2.0% heat-inactivated fetal calf serum and placed at 35°C in a humidified environment with 5% CO2. Six days later, a second overlay containing 0.5% agarose, 25 mM MgCl2, and neutral red (final concentration, 0.02%) was added. Visible plaques were counted 6 to 24 h later. In some instances, the agarose overlays were subsequently removed from the cell sheets and the cells were processed for immunologic detection of viral replication foci as described below.
Radioimmunoassays for HAV antigen. Suspensions of gradient-purified virus (clones A and B and p16) were standardized for viral RNA content by cDNA-RNA hybridization. Serial dilutions of standardized virus suspensions were then tested for antigen content by a solid-phase radioimmunoassay employing human polyclonal antibody for both virus capture and detection (30) and for ability to bind HAVspecific murine monoclonal antibodies by an indirect immunoassay method (34) .
Radioimmunofocus assays for HAV. Quantitation of infectious virus was based on the autoradiographic detection of foci of HAV replication developing in cell sheets (BS-C-1 or FRhK-4) maintained beneath 0.5% agarose overlays, following fixation of the cell sheet with acetone and staining with 1251-labeled antibody to HAV (JC, polyclonal postconvalescent human immunoglobulin G) (27, 29) . Cell sheets were assayed for replication foci Replication advantage of antigenic variant during persistent infection. We utilized an epitope-specific radioimmunofocus assay (28) subsequent serial passage of this virus in FRhK-4 cells at 3-day intervals resulted in selection of virus with a normal antigenic phenotype (Fig. 3B) . Virus with the escape mutant phenotype represented only 3 to 8% of all infectious virus after three to four serial passages in FRhK-4 cells, although both viral phenotypes replicated to higher titers upon recovery from persistently infected BS-C-1 cells and subsequent serial passage in FRhK-4 cells.
To determine whether virus with the escape phenotype could be reselected if persistent infection was reestablished with virus recovered from FRhK-4 cells after serial passage, we inoculated BS-C-1 cells with virus harvested after serial passage 4 in FRhK-4 cells (92% wild-type antigenic phenotype, Fig. 3B ). These cells were subcultured at weekly intervals for 4 weeks. The yield of each virus type dropped significantly in harvests made after the third subculture of these infected cells (Fig. 3C) . The proportion of virus with the escape phenotype increased with time, however. One month (four cell culture passages) after infection, such virus represented 19% of the total virus yield. Further subculture of these persistently infected cells was not done. Thus, the clone A escape variant appeared to have a slight replication advantage over nonmutant virus during persistent infection in BS-C-1 cells.
We did further experiments to determine whether the selection of viruses with different antigenic phenotypes shown in Fig. 3B and 2C reflected a change in host cell type (BS-C-1 cells versus FRhK-4 cells) or a change in passage conditions (persistently infected cell passage versus serial virus passage). First, pHM175 virus harvested from p23 of the persistently infected BS-C-1 cells (Fig. 3A, 99% Fig. 3B ) or subtle differences in the cells used in these experiments. In a separate experiment, pHM175 virus recovered from However, the data shown in Fig. 3B suggested that virus in pHM175 harvests which retained normal antigenicity shared a capacity for relatively rapid replication with the escape mutant. Thus, we clonally isolated antigenically normal virus (HM175/18f virus, or clone B) from radioimmunofocus assay overlays after infection of BS-C-1 cells with pHM175 virus. Unlike clone A virus, which was selected for its ability to induce distinct plaques, clone B virus was selected for its continuing ability to bind K24F2 antibody. However, clone B virus generated distinct plaques in BS-C-1 cells maintained under agarose and stained with neutral red (data not shown). Like clone A, clone B virus had a rapidly replicating phenotype, forming large radioimmunofoci within 7 days of inoculation of cells. Furthermore, autoradiograms of the 125I-anti-HAV-stained cell sheets often showed replication foci with central areas of cell necrosis (Fig. 1B) (Table 2) . However, the detection of antigen from clone A was likely to have been biased by its altered antigenicity, which was evident even in polyclonal radioimmunoassays (see below). Taken together, these results indicate that the cytopathic effect of pHM175 virus variants occurs in both cell types and is not restricted to FRhK-4 cells as first suggested (10) . Furthermore, the neutralization escape phenotype of clone A was neither necessary for nor specifically associated with the ability of virus to replicate rapidly and generate a cytopathic effect in cell culture.
Comparative antigenicity and thermal stabilities of cytopathic virus clones A and B. We did a detailed analysis of the antigenicity of virus clones A and B in comparison with that of the noncytopathic p16 HM175 virus, using a panel of neutralizing murine monoclonal antibodies assembled from several laboratories. Standardized quantities of each virus (determined by cDNA-RNA hybridization) were tested for ability to bind monoclonal antibodies in an indirect radioimmunoassay (34) . While these assays demonstrated that clone A virus was poorly recognized by many of the monoclonal antibodies, the clone B variant was indistinguishable from the noncytopathic p16 HM175 virus (Fig. 4) . These findings were confirmed in subsequent monoclonal antibody neutralization assays (data not shown). When standardized quantities of each virus were tested in a polyclonal radioimmunoassay, there was a marked reduction in the amount of antigenic activity associated with the clone A virus (Fig. 5) . This finding supports the concept that the HAV capsid displays an immunodominant antigenic site on its surface (34, 39) .
Since it has been suggested that cytopathic HAV variants have reduced virion stability at elevated temperatures (1), we examined the thermal stability of virus clones A and B. Crude cell lysates containing p16, clone A, and clone B viruses were heated for 10 min at temperatures ranging from 40 to 90°C and then assayed for infectious virus ( Fig. 6A and B) and for HAV antigen detectable in the polyclonal solidphase radioimmunoassay (Fig. 6C and D) . These studies failed to demonstrate reproducible differences between the thermal stability of the p16 virus and that of the cytopathic clone A and clone B variants, in terms of either loss of infectivity or loss of antigenicity. The addition of 1 M Mg2" (Fig. 6B and D) resulted in an increase of approximately 20°C in the 50% survival point of all three viruses, as might be expected from previous studies (38) .
Mutations present in cytopathic variants. We determined the nearly complete genomic sequences (nucleotides 30 to 7478) of virus clones A and B, as well as HM175/24a, a third virus clone (clone C) that was conventionally plaque purified from pHM175 virus stock after serial passage in FRhK-4 cells (9) . These sequences were compared with those previously determined for wild-type HM175 virus (three passages in marmosets) (8) and cell culture-adapted p16 HM175 virus (22) , which is closely related to the virus used to initiate the I ' I I Tables 3 (nucleotide changes) and 4 (amino acid changes). Mutations present in virus clones A and B will be discussed first.
Mutations present in p16 HM175 virus (from wild-type sequence) and associated with initial adaptation of the virus to growth in cell culture (22) were found to be generally present in both virus clones A and B, as might be expected. However, both cytopathic virus clones were found to have a number of additional mutations in all regions of the genomes. Thus, the nucleotide sequence of clone A contains a total of 34 mutations from that of p16 virus, predicting 19 amino acid changes. Clone B has 31 mutations, predicting 17 amino acid changes. Virus clones A and B were found to share an identical 5' sequence (bases 30 to 1677). Within the 5' nontranslated region, both viruses had four mutations in addition to those already present in p16 HM175. The most remarkable of these mutations is a 14-base insertion between bases 154 and 155, representing a direct repeat of bases 141 to 154. The sequences of the two viruses differed within the P1 region, with the escape mutant, clone A, having nonsilent mutations resulting in amino acid substitutions at residues DISCUSSION The spontaneous emergence of an antigenic variant during persistent HAV infection, in the absence of selective antibody pressure, contrasts with the absence of significant antigenic variation evident among different wild-type human HAV strains (26) . This finding suggests that HAV strains that have undergone considerable passage in cell culture (particularly as persistent infections) should be carefully examined for altered antigenicity before they are considered for use in diagnostic assays or as vaccines. Based on mutations we have identified previously in purposefully selected HAV neutralization escape variants (34), the mutation at residue 3-070 is most likely responsible for the antigenic variation displayed by clone A virus. However, a role for the other capsid mutations (especially that at has not yet been excluded.
All three virus clones that we studied were cytopathic and had a rapid replication phenotype (replication foci developing in less than 7 days). A significant contribution of the P1 region mutations to this replication phenotype seems unlikely, given the fact that these virus clones have different mutations in the capsid proteins. However, the pattern of mutations within the P1 region was similar in the virus clones (Table 4) Palmenberg (33) , and near the carboxy terminus of VP1 (residues 1-271 and 1-276). Mutations predicting amino acid substitutions at similar sites in HAV capsid proteins (residue 3-070, 1-273, or 1-276) have been reported in cDNA derived from other independently isolated and cell culture-adapted virus variants (7, 36) . Thus, these regions of the capsid (18, 20) . There are few other mutations that could be responsible for the differential growth properties of clones A and B: the nontranslated regions of the genomes of these viruses are identical (Table 3) , and the only amino acid differences in proteins other than the capsid proteins are in 3CprO (Table 4) . Less efficient processing of the P1 polyprotein by the 3CPrO of clone A could explain the reduced efficiency of replication of this virus clone during serial passage. Furthermore, mutations in 3CPFO might also affect viral RNA synthesis, as Andino et al. (2) have demonstrated a role for 3CPrO of poliovirus in RNA replication. Further studies will be required to determine whether it is the P1 or 3CP" mutations that are responsible for the different growth properties of these viruses.
A comparison of the nearly complete genomic sequences of all three cytopathic virus clones revealed discontinuous regions of identity and nonidentity with respect to mutations from the p16 genomic sequence (Table 3) . These findings provide strong, albeit indirect, evidence for genetic recombination among these HAV variants (Fig. 7) . Although the temporal order in which these mutations accumulated during persistent infection is not known, it is much less likely that the observed sequence microheterogeneity occurred simply as the result of the selection of favorable random mutations followed by additional mutations in each variant. Such a hypothesis fails to explain the striking pattern of identity and nonidentity with respect to both silent and nonsilent nucleotide base changes. Recombination is well recognized among certain other picornaviruses (24) , and it is not sur- Table 3 and Fig. 7 , probably derived from distinct recombination events (different crossover points) within the P3 region. Analysis of the nucleotide sequences of these three cytopathic virus clones thus suggests that mutations in the 5' and 3' nontranslated and P2/P3 regions are primarily responsible for their growth characteristics. Of all the viral proteins, the changes in 2C are most striking in both number and type (Table 4) . Of the eight amino acid substitutions (from p16 HM175) present in 2C of all three viral clones, five are nonconservative in nature. Two sites within the protein appear particularly affected, with mutations at residues 22 and 24 and at 142 and 144. Almost all the mutations are in the amino half of the protein and none are near Gly-197 or Pro-245, which align with guanidine resistance and guanidine dependence sites, respectively, that have been identified in 2C of type 1 poliovirus (15) . A role for 2C in the structural organization of picornaviral replication complexes has recently been proposed, with 2C putatively interacting jointly with viral RNA and membrane protrusions on the rough endoplasmic reticulum (3) . Such a role would make 2C a likely determinant of host range. Indeed, host range mutants of human rhinovirus have been shown to have mutations within protein 2C (43) .
Our findings are consistent with the idea that evolution of the rapid replication and cytopathic phenotype of HAV represents a further adaptation of the virus to cell culture. Mutations within 2B and 2C and in the 5' nontranslated region of HAV have been shown to be associated with enhanced growth in cell culture (6, 7, 13, 16, 22) . The involvement of the 5' nontranslated region and 2B and 2C suggests that adaptation primarily affects viral RNA replica-
